Page 6 - Efficacy Data News Today

Press release content from PR Newswire. The AP news staff was not involved in its creation.

The efficacy data wasnt strong enough and i felt that even a small number of parents who moved forward winning it with they were hoping for. its got moderna looking good, and will probably find out in the coming weeks set of three dose pfizer series will work as well. when that happens, it will be a very different situation for a lot of families, like mine, because we do alter our behavior to keep our four year old safe. honestly, its been a long time coming and the fda needs to move. >> the pro...

/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...

All children. i also mentioned, dr. reiner, the city in china where a million people are now under lockdown after just one positive case in the city. and that follows the brutal lockdowns that weve been watching play out in shanghai and beyond in china. this comes back to china being so committed to its zero covid strategy. what does this say to you about that zero covid strategy and where this goes from here? >> well, it cant work in china. the problem in china is that they have vaccinated an e...

Group. this were no cases of myo carditis, however they pointed out a flaw saying they did not include all the diagnostic codes which may have accounted for not being able to catch some of of the rare cases. for me, i can say the decision to boost healthy adolescence, millions potentially without any efficacy data, you know, is perplexing, and i have to imagine that i dont know if that would have happened if you still had some of those higher level directors there in the summer that quit over th...

In my mind, as you said, in this conversation with dr. murthy, two things that i hope that people see this -- parents see out of this is that this was not a -- this was a change in strategy, but i think based on the fact that it seemed like there was more data but maybe not as much data on two doses to justify getting those out there, but there was, for efficacy, but for safety, this was not a safety signal. those two doses are already shown to be safe from the data that pfizer shared. it was re...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

News Release Takeda Submits New Drug Application for Novavax COVID-19 Vaccine Candidate in Japan ... | December 16, 2021

/PRNewswire/ -- Eisai Inc. announced today that new data on its antiepileptic drug FYCOMPA® (perampanel) CIII will be presented at the 75th American Epilepsy...

/PRNewswire/ -- Eisai Inc. announced today that new data on its antiepileptic drug FYCOMPA® (perampanel) CIII will be presented at the 75th American Epilepsy...